The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Once-daily aminoglycoside therapy
Open accessAbstract
The once-daily administration of aminoglycosides is an attractive concept. In animal experiments and clinical trials, there is either a reduction in or no influence on the risk of toxicity. Less frequent dosing reduces the contact time between host tissue binding sites and drug. Thanks to the PAE and perhaps other as-yet-unrecognized factors, the fall in the level in serum below the MIC does not appear to impair antibacterial efficacy; in fact, the higher peak level in serum may enhance drug efficacy early in a dosage interval. In neutropenic patients, the in vivo PAE may be lost or small-colony variants with a shorter PAE may be selected unless a concomitant beta-lactam is administered. Because it will be some time before data from clinical trials in the United States are available, because the results from the international trials are encouraging, and because there is potential benefit to patients, it seems reasonable for infectious diseases consultants to cautiously initiate the educational process necessary to implement once-daily aminoglycoside therapy in their institutions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moore, R. D., Lietman, P. S., & Smith, C. R. (1987) · Journal of Infectious Diseases · doi:10.1093/infdis/155.1.93 · Cited by 1,139
Correlation of Antimicrobial Pharmacokinetic Parameters with Therapeutic Efficacy in an Animal Model
Vogelman, B., Gudmundsson, S., Leggett, J., Turnidge, J., Ebert, S., & Craig, W. A. (1988) · The Journal of Infectious Diseases · doi:10.1093/infdis/158.4.831 · Cited by 720
Mechanism of bactericidal action of aminoglycosides
Davis, B. D. (1987) · Microbiological Reviews · doi:10.1128/mmbr.51.3.341-350.1987 · Cited by 620
Moore, R. D., Smith, C. R., & Lietman, P. S. (1984) · Journal of Infectious Diseases · doi:10.1093/infdis/149.3.443 · Cited by 390
Experience in Monitoring Gentamicin Therapy during Treatment of Serious Gram-Negative Sepsis
Noone, P., Parsons, T. M. C., Pattison, J. R., Slack, R. C. B., Garfield-Davies, D., & Hughes, K. (1974) · BMJ · doi:10.1136/bmj.1.5906.477 · Cited by 347
Role of pharmacokinetics in the outcome of infections
Drusano, G. L. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.3.289 · Cited by 330
Kinetics of antimicrobial activity
Vogelman, B., & Craig, W. A. (1986) · The Journal of Pediatrics · doi:10.1016/s0022-3476(86)80754-5 · Cited by 315
Postantibiotic Suppression of Bacterial Growth
Bundtzen, R. W., Gerber, A. U., Cohn, D. L., & Craig, W. A. (1981) · Clinical Infectious Diseases · doi:10.1093/clinids/3.1.28 · Cited by 311
Powell, S. H., Thompson, W. L., Luthe, M. A., Stern, R. C., Grossniklaus, D. A., Bloxham, D. D., Groden, D. L., Jacobs, M. R., DiScenna, A. O., Cash, H. A., et al. (1983) · Journal of Infectious Diseases · doi:10.1093/infdis/147.5.918 · Cited by 272
In Vivo Postantibiotic Effect in a Thigh Infection in Neutropenic Mice
Vogelman, B., Gudmundsson, S., Turnidge, J., Leggett, J., & Craig, W. A. (1988) · Journal of Infectious Diseases · doi:10.1093/infdis/157.2.287 · Cited by 259
Tran Ba Huy, P., Bernard, P., & Schacht, J. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112463 · Cited by 239
CRAIG, W. A., & VOGELMAN, B. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-6-900 · Cited by 228
Once-daily dosing decreases renal accumulation of gentamicin and netilmicin
Verpooten, G. A., Giuliano, R. A., Verbist, L., Eestermans, G., & De Broe, M. E. (1989) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1989.4 · Cited by 201
Kapusnik, J. E., Hackbarth, C. J., Chambers, H. F., Carpenter, T., & Sande, M. A. (1988) · Journal of Infectious Diseases · doi:10.1093/infdis/158.1.7 · Cited by 183
Bennett, W. M., Plamp, C. E., Gilbert, D. N., Parker, R. A., & Porter, G. A. (1979) · Journal of Infectious Diseases · doi:10.1093/infdis/140.4.576 · Cited by 183
Self-citationAminoglycoside-induced hearing loss in humans
Brummett, R. E., & Fox, K. E. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.6.797 · Cited by 178
Gerber, A., Craig, W. A., Brugger, H. P., Feller, C., Vastola, A. P., & Brandel, J. (1983) · The Journal of Infectious Diseases · doi:10.1093/infdis/147.5.910 · Cited by 150
ter Braak, E. W. M. T., de Vries, P. J., Bouter, K. P., van der Vegt, S. G. L., Gc, D., Nortier, J. W. R., van Dijk, A. P. J., Verkooyen, R. P. A. J., & Verbrugh, H. A. (1990) · The American Journal of Medicine · doi:10.1016/0002-9343(90)90099-y · Cited by 148
Postantibiotic effect of imipenem on Pseudomonas aeruginosa
Bustamante, C. I., Drusano, G. L., Tatem, B. A., et al. (1984) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.26.5.678 · Cited by 138
Polyaspartic Acid Prevents Experimental Aminoglycoside Nephrotoxicity
Gilbert, D. N., Wood, C. A., Kohlhepp, S. J., et al. (1989) · The Journal of Infectious Diseases · doi:10.1093/infdis/159.5.945 · Cited by 125
Self-citationDoes administration of an aminoglycoside in a single daily dose affect its efficacy and toxicity?
Nordström, L., Ringbert, H., Cronberg, S., Tjernström, Ö., & Walder, M. (1990) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/25.1.159 · Cited by 107
Nephrotoxicity of gentamicin and tobramycin given once daily or continuously in dogs
Reiner, N. E., Bloxham, D. D., & Thompson, W. L. (1978) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/4.suppl_a.85 · Cited by 104
Netilmicin in the Treatment of Gram-Negative Bacteremia: Single Daily versus Multiple Daily Dosage
Sturm, A. W. (1989) · The Journal of Infectious Diseases · doi:10.1093/infdis/159.5.931 · Cited by 101
Wood, C. A., Norton, D. R., Kohlhepp, S. J., Kohnen, P. W., Porter, G. A., Jr., Houghton, D. C., Brummett, R. E., Wm, B., & Gilbert, D. N. (1988) · The Journal of Infectious Diseases · doi:10.1093/infdis/158.1.13 · Cited by 88
Self-citationVancomycin enhancement of experimental tobramycin nephrotoxicity
Wood, C. A., Kohlhepp, S. J., Kohnen, P. W., Houghton, D. C., & Gilbert, D. N. (1986) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.30.1.20 · Cited by 86
Self-citationHollender, L. F., Bahnini, J. M., de Manzini, N., Lau, W. Y., Fan, S. T., Hermansyur, K., Benny, P., Husni, A. N., Sutjipto, & Lorber, R. R. (1989) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/23.5.773 · Cited by 78
Roosendaal, R., Bakker‐Woudenberg, I. A. J. M., Raffe, M. V. D. B.-V., Berg, J., & MICHEL, M. F. (1989) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01963774 · Cited by 70
Choice of drug and dosage regimen: Two important risk factors for aminoglycoside nephrotoxicity
Broe, M. E. D., Giuliano, R. A., & Verpooten, G. A. (1986) · The American Journal of Medicine · doi:10.1016/0002-9343(86)90488-2 · Cited by 70
Dosage Schedules of Antimicrobial Agents: A Historical Review
Kunin, C. M. (1981) · Clinical Infectious Diseases · doi:10.1093/clinids/3.1.4 · Cited by 67
Constant Infusions vs. Intermittent Doses of Gentamicin Against Pseudomonas aeruginosa in Vitro
Gerber, A., Wiprachtiger, P., Spichiger, U., & Lebek, G. (1982) · The Journal of Infectious Diseases · doi:10.1093/infdis/145.4.554 · Cited by 62
Huy, P. T. B., & Deffrennes, D. (1988) · Acta Oto-Laryngologica · doi:10.3109/00016488809119511 · Cited by 62
Mordenti, J. J., Quintiliani, R., & Nightingale, C. H. (1985) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/15.suppl_a.313 · Cited by 46
In-vivo assessment of in-vitro killing patterns of Pseudomonas aeruginosa
Gerber, A., & Segessenmann, C. (1985) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/15.suppl_a.201 · Cited by 36
Herşcovici, L., Grise, G., Thauvin, C., Lemeland, J. F., & Fillastre, J. P. (1988) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365548809032439 · Cited by 33
Empiric Therapy for Infections in Patients With Granulocytopenia
Feld, R. D. (1984) · Archives of Internal Medicine · doi:10.1001/archinte.1984.00350170165027 · Cited by 28
Dissociation of maximum concentration of kanamycin in plasma and perilymph from ototoxic effect
Davis, R. R., Brummett, R. E., Bendrick, T. W., & Himes, D. (1984) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/14.3.291 · Cited by 23
Wc, E., Ra, P., Houghton, D. C., Dn, G., Porter, G. A., DeFehr, J., & Wm, B. (1980) · PubMed · Cited by 21
Influence of Dosage Regimen on Experimental Tobramycin Nephrotoxicity
Olier, B., Viotte, G., Morin, J., & Fillastre, J. P. (2009) · Chemotherapy · doi:10.1159/000238225 · Cited by 21
Bamonte, F., Dionisotti, S., Gamba, M., Ongini, E., Arpini, A., & Melone, G. (2009) · Chemotherapy · doi:10.1159/000238747 · Cited by 20
One Shot of High-Dose Amikacin: A Working Hypothesis
Yourassowsky, E., van der Linden, M., & Crokaert, F. (2009) · Chemotherapy · doi:10.1159/000238741 · Cited by 12
Cited by
Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1)
Kellum, J. A., Lameire, N., & for the KDIGO AKI Guideline Work Group (2013) · Critical Care · doi:10.1186/cc11454 · Cited by 2,827
Versatility of Aminoglycosides and Prospects for Their Future
Vakulenko, S. B., & Mobashery, S. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.3.430-450.2003 · Cited by 643
Experience with a once-daily aminoglycoside program administered to 2,184 adult patients
Nicolau, D. P., Freeman, C. D., Belliveau, P. P., Nightingale, C. H., Ross, J. W., & Quintiliani, R. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.3.650 · Cited by 641
Single or multiple daily doses of aminoglycosides: a meta-analysis
Barza, M., Ioannidis, J. P., Cappelleri, J. C., & Lau, J. (1996) · BMJ · doi:10.1136/bmj.312.7027.338 · Cited by 450
Rybak, M. J., Abate, B. J., Kang, S. L., Ruffing, M. J., Lerner, S. A., & Drusano, G. L. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.7.1549 · Cited by 431
Metadata
- Authors
- Gilbert, D. N.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 1991-03
- Volume
- 35
- Issue
- 3
- Pages
- 399-405
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2114422486
- Cited by
- 324
- References
- 40
- FWCI
- 22.83
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.